Evidence map›Paper›PMID 37631955›Full record

ArticleVaccines2023

Sources of COVID-19 Vaccine Promotion for Pregnant and Lactating Women in Bangladesh.

Berhaun Fesshaye, Sydney A Wade, Clarice Lee, Prachi Singh, Eleonor Zavala, Hasmot Ali, Hafizur Rahman, Towfida Jahan Siddiqua, Shirina Atker, Ruth A Karron and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Berhaun FesshayeInternational Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21231, USA.
Sydney A WadeJohns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Clarice LeeInternational Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21231, USA.
Prachi SinghInternational Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21231, USA.ORCID 0000-0001-6013-1916
Eleonor ZavalaDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Hasmot AliJiVitA Project, Johns Hopkins University, Rangpur 8240, Bangladesh.
Hafizur RahmanJiVitA Project, Johns Hopkins University, Rangpur 8240, Bangladesh.
Towfida Jahan SiddiquaJiVitA Project, Johns Hopkins University, Rangpur 8240, Bangladesh.
Shirina AtkerJiVitA Project, Johns Hopkins University, Rangpur 8240, Bangladesh.
Ruth A KarronDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Rupali J LimayeInternational Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21231, USA.
Johns Hopkins University · US

Funding

Bill & Melinda Gates Foundation INV-016977
6 · The paper itself

Abstract

COVID-19 vaccines are an effective public health intervention to reduce COVID-19-related morbidity and mortality. Given that pregnant and lactating women have a higher risk of severe COVID-19 complications, it is paramount to understand the factors that inform vaccine decision-making among this population. In this study, we sought to identify facilitators and barriers to COVID-19 vaccine acceptance and vaccine promotion in pregnant and lactating women in Bangladesh. We conducted 40 in-depth interviews with 12 pregnant women, 12 lactating women, and 16 health workers from one urban and four rural communities in Bangladesh. We used a grounded theory approach to identify emerging themes. Our results suggest that health workers and religious leaders played key roles in promoting COVID-19 vaccines in this population. Further, we found that the culture of trust in public health authorities and the existing vaccine infrastructure facilitated vaccine promotion. However, changes in vaccine eligibility and myths and rumors acted as both facilitators and barriers to vaccine promotion within our study. It is crucial that maternal immunization vaccine promotion efforts push pregnant and lactating women toward vaccine acceptance to protect the health of mothers and their babies. Additionally, as new maternal vaccines are developed and licensed, understanding how to best promote vaccines within this group is paramount.

Indexed as

BangladeshCOVID-19maternal immunizationqualitativetrustvaccines

Identifiers

PMID37631955
PMCPMC10459640
OpenAlexW4386030554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.